2m 2m 2m 2m 2m 2m 2m
NEUROPACE (NPCE)
NASDAQ
$12.49-$0.20 (-1.58%)
Price as of Nov 11, 2026 7:50 PM EST- $435.6MMarket Cap
- -5.93%1-Year Change
- Medical DevicesIndustry
NEUROPACE (NPCE)
$12.49-$0.20 (-1.58%)
NPCE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $12.69 | ||
Change | -$0.43 (-3.28%) | ||
Open | $13.09 | ||
High | $13.35 | ||
Low | $12.65 | ||
Previous Close | $13.12 | ||
Volume | 133,741 | ||
30-Day Average Volume | 118,495 | ||
1-Week Change | 3.09% | ||
1-Month Change | 0.16% | ||
1-Year Change | -5.93% | ||
3-Year Change | 61.66% | ||
5-Year Change | -19.68% | ||
Fundamentals | |||
Shares Outstanding | 34.3M | ||
Total Assets | $97.0M | ||
Market Cap | $435.6M | ||
Enterprise Value | $482.1M | ||
Period: QTR TTM FY | |||
Revenue | $22.8M | ||
Net Income | -$6.2M | ||
Free Cash Flow | -$4.0M | ||
EBIT | -$4.7M | ||
EBITDA | -$4.6M | ||
Net Working Capital | $68.8M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -104 | ||
Enterprise Value/Revenue | 21 | ||
P/B | 37 | ||
P/E | -70 | ||
PEG | -7 | ||
Price/Free Cash Flow | -108 | ||
Price/Operating Cash Flow | -112 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue